Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.4000 (-1.46%) ($39.8000 - $42.4000) on Tue. Jul. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.1% (three month average) | RSI | 45 | Latest Price | $40.4000(-1.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) SKYY(7%) VT(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -3.05% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-4%) GDX(-4%) VCSH(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.05% (StdDev 6.1%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $41.66 | 5 Day Moving Average | $40.86(-1.13%) | 10 Day Moving Average | $41.05(-1.58%) | 20 Day Moving Average | $41.66(-3.02%) | To recent high | -14.9% | To recent low | 39.3% | Market Cap | $796m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |